Drug Development Strategy
Investors do not write checks for cool scientific ideas. They fund strategies with the potential to transform science into viable drug products. We build those strategies.
What Strategy Is NOT
Most teams confuse strategy with three things that are not strategy. Goals are not strategy. A plan is not strategy. A mission statement is not strategy. Strategy is the set of integrated choices that position your program to win. It answers five questions, and if you cannot answer all five, you do not have a strategy yet.
- Goals tell you where you want to end up. They do not tell you how to get there.
- Plans list activities and timelines. They do not explain why those activities matter over alternatives.
- Mission statements describe intent. They do not force the hard trade-offs that separate winners from the rest.
The Challenge
Drug development is expensive, slow, and unforgiving. Without a clear strategy, teams burn cash on the wrong studies, miss regulatory milestones, and lose investor confidence.
Most failures are not scientific. They are strategic. Wrong target, wrong timing, wrong regulatory pathway, wrong investment in the wrong studies at the wrong phase.
Our Approach
We start with your science and work backwards from the market. What does the ideal product look like? What regulatory pathway gets you there fastest? What studies are truly necessary versus nice-to-have?
The result is a Strategy on a Page: executable, fundable, and aligned with your resources. Not a theoretical 200-page document that sits on a shelf.
The Strategic Choice Cascade
Every strategy we build follows a proven framework of five integrated choices. Each choice reinforces the others. Skip one, and the whole structure collapses.
Winning Aspiration
What does winning look like for your program? Not a vague mission. A specific, measurable definition of success for patients, investors, and your team.
Where to Play
Which indication, patient population, geography, and market segment will you target? Choosing where to play means choosing where not to play.
How to Win
What is your competitive advantage in that chosen space? Differentiated mechanism, faster pathway, better safety profile, or superior delivery.
Capabilities Required
What must your team be able to do exceptionally well? Manufacturing, clinical operations, regulatory navigation, or commercial partnerships.
Management Systems
What processes, structures, and decision frameworks keep the strategy on track? Go/no-go gates, milestone reviews, and resource allocation rules.
How We Build Your Strategy
Discovery
Deep review of your science, goals, and constraints. We map the full picture before making any recommendations.
Landscape Analysis
Competitive intelligence, regulatory precedent review, and market assessment to identify gaps and position your program.
Strategy Design
Build the Strategy on a Page: milestones, timelines, go/no-go criteria, regulatory pathway, and budget framework.
Execution Support
Ongoing advisory as you execute. We adapt the strategy as new data arrives and the competitive landscape shifts.
What You Get
Frequently Asked Questions
Build Your Strategy
Every drug program is unique. Tell us about yours and we will show you the clearest path from where you are to where you need to be.
Book a Discovery Call